교수진 소개
- Name
- Jinsoo CHUNG, M.D., Ph.D.(adjunct professor)
- Faculty Appointment
(title, department)
- Adjunct Professor, GCSP
Director, Hospital, National Cancer Center
- Area of Expertise
- Urologic Oncology
- E-mail
- cjs5225@ncc.re.kr
- Work Experience
- Head, Center for Prostate Cancer, Hospital, National Cancer Center
Chief, Department of Urology, Hospital, National Cancer Center
Chief, Emergency Room, Hospital, National Cancer Center
- Educational Background
- 2001 PhD, Seoul National University Graduate School of Medicine
1994 MS, Seoul National University Graduate School of Medicine
1989 MD, Seoul National University College of Medicine
- Research Interests
- As a specialist in Urologic Oncology, I have been maintaining active research programs, with interests centered on clinical and translational research on the treatment of Renal cell carcinoma (including biomarkers for advanced RCC with targeted sequencing, tissue microarray, prognostic factors, etc) and running several clinical trials on treatment of advanced RCC and adjuvant trials on RCC (with several targeted agents and immune check-point inhibitors, including several Phase II or III clinical trials)
- International Collaboration
- 2004~2005 School of Medicine, UCLA, USA.
- Achievements
- 2018 SCI-E Prognostic significance of nephrectomy in metastatic renal cell carcinoma treated with systemic cytokine or targeted therapy: A 16-year retrospective analysis: Scientific reports. 8(1):2974~2974 (4.259)
2018 SCI Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma: Scientific Reports. 8;202:1~8 (4.259)
2018 SCI-E Retrospective analysis of 25 immunohistochemical tissue markers for differentiating multilocular cystic renal neoplasm of low malignant potential and multicystic renal cell carcinoma: Histology and histopathology. Online:Published (2.025)
2017 SCI-E Lifestyle Risk Prediction Model for Prostate Cancer in a Korean Population: Cancer Research and Treatment. Online:Published (3.772)
2017 SCI-E Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma: International Journal of Clinical Oncology. 23(1):142~150 (2.064)
2017 SCI-E Second Primary Cancer Risk Among Kidney Cancer Patients in Korea: A Population-Based Cohort Study: Cancer Research and Treatment. 50(1):293~301 (3.772)
2017 기타 The retrospective analysis of prognostic significance of smoking status in bladder cancer: Korean Journal of Urological Oncology. 15:1~10 (0)
2017 SCI-E Recommended oral sodium bicarbonate administration for urine alkalinization did not affect the concentration of mitomycin-C in non-muscle invasive bladder cancer patients: oncotarget. Online:Published (5.168)
2017 SCI-E A retrospective comparative study of progression-free survival and overall survival between metachronous and synchronous metastatic renal cell carcinoma in intermediate or poor risk patients treated with VEGF-targeted therapy: Oncotarget. 8(55):93633~93643 (5.168)
2017 SCI-E Establishment and Application of Prostate Cancer CirculatingTumor Cells in the Era of Precision Medicine: BioMed Research International. 2017:1~9 (2.476)
2017 기타 Renal myxofibrosarcoma in a woman: A cese report and literature review: Journal of Cytology and Histology. 8:4~8 (1.02)
2017 SCI-E Survival outcomes of double- and triple-sequential targeted therapy in patients with metastatic renal cell carcinoma: a retrospective comparison: Oncotarget. Online:Published (5.168)
2017 SCI-E Clinicopathologic Characteristics and Prognosis of Xp11.2 Translocation Renal Cell Carcinoma: Multicenter, Propensity Score Matching Analysis: Clinical Genitourinary Cancer. 15(5):e819~e825 (2.535)
2017 SCI-E Gonadal and Sexual Dysfunction in Childhood Cancer Survivors: Cancer Research and Treatment. Online:Published (3.772)
2017 SCI-E Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction: PLOS one. 12(9):e0184965~e0184965 (2.806)
2017 SCI-E Impact of preoperative thrombocytosis on prognosis after surgical treatment in pathological T1 and T2 renal cell carcinoma: results of a multi-institutional comprehensive study: Oncotarget. 8(38):64449~64458 (5.168)
2017 SCI-E Sex-Specific Prognostic Significance of Obesity in Nonmetastatic Clear-Cell Renal-Cell Carcinoma in Korea: A Large Multicenter Cohort Analysis: Clinical Genitourinary Cancer. Online:Published (2.535)
2017 SCI-E The effect of predisposing atheroembolic risk factors on renal functional recovery between laparoscopy and open technique in patients with T1-stage renal cell carcinoma who underwent partial nephrectomy: A retrospective comparison study: Japanese Journal of Clinical Oncology. 47(9):876~882 (1.905)
2017 SCI-E Effect of renal embolization in patients with synchronous metastatic renal cell carcinoma: A retrospective comparison of cytoreductive nephrectomy and systemic medical therapy: Oncotarget. 8(30):49615~49624 (5.168)
2017 SCI-E The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry: PLOS ONE. Online:Published (2.806)
2017 SCI-E Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naive, unresectable metastatic renal cell carcinoma: PLOS ONE. 12(5):e0177975~e0177975 (2.806)
2017 SCI-E Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy: BMC Cancer. 17(1):364~364 (3.288)
2017 SCI-E Primary tumor characteristics are important prognostic factors for sorafenib-treated patients with metastatic renal cell carcinoma: a retrospective multicenter study: BioMed Research International. 2017:9215930~9215930 (2.476)
2017 SCI-E Surgical treatment of renal cell carcinoma: Can morphological features of inferior vena cava tumor thrombus on computed tomography or magnetic resonance imaging be a prognostic factor?: International Journal of Urology. 24(2):102~109 (1.844)
2016 SCI-E Clinical Significance of Subclassification of Papillary Renal Cell Carcinoma : Comparison of Clinicopathologic Parameters and Oncologic Outcomes Between Papillary Histologic Subtypes 1 and 2 Using the Korean Renal Cell Carcinoma Database: Clinical Genitourinary Cancer. 15(2):e181~e186 (2.599)
2016 SCI-E Pretreatment prognostic nutritional index is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with targeted therapy: Clinical Genitourinary Cancer. 15(1):100~111 (2.599)
2016 SCI Prostate Cancer in a Patient With a Family History of BRCA Mutation: a Case Report And Literature Review: Journal of Korean Medical science. 32(2):377~381 (1.256)
2016 기타 The Correlation of Tissue-Based Biomarkers in Primary and Metastatic Renal Cell Carcinoma Lesions: A Tissue Microarray Study: Korean Journal of Urological Oncology. 14:152~158 (0)
2016 기타 Risk Determination for Localised Renal Cell Carcinomas under 4 cm or Less: A Multi-institutional Analysis: Korean Journal of Urological Oncology. 14:138~143 (0)
2016 SCI-E Baseline Chronic Kidney Disease and Ischemic Method of Partial Nephrectomy Are Important Factors for the Short- and Long-Term Deterioration in Renal Function for Renal Cell Carcinoma Staged T1-T2: A Retrospective Single Center Study: BioMed Research International. 2016:5398381~5398389 (2.134)
2016 SCI A Prospective Multicenter Trial of the Efficacy and Tolerability of Neoadjuvant Sunitinib for Inoperable Metastatic Renal Cell Carcinoma: Journal of Korean Medical Science. 31:1983~1988 (1.256)
2016 SCI Impact of Young Age at Diagnosis on Survival in Patients with Surgically Treated Renal Cell Carcinoma: a Multicenter Study: Journal of Korean Medical Science. 31:1976~1982 (1.256)
2016 SCI-E Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Nonmetastatic Renal Cell Carcinoma: A Large, Multicenter Cohort Analysis: BioMed Research International. 2016:5634148~5634148 (2.134)
2016 SCI-E Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review: World Journal of Surgical Oncology. 14(1):270~270 (1.286)
2016 SCI-E Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea: Cancer Research and Treatment. Online:Published (4.245)
2016 SCI-E A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy: BMC cancer. 16(1):577~577 (3.265)
2016 SCI-E Systemic treatments for metastatic renal cell carcinoma: 10-year experience of immunotherapy and targeted therapy: cancer research and treatment. 48(3):1092~1101 (4.245)
2016 SCI Surgical margin does not influence recurrence rate in pT1 clear cell renal cell carcinoma after partial nephrectomy : A multicenter study: Journal of Surgical Oncology. 114:70~74 (3.151)
2016 SCI Renal cell carcinoma in end-stage renal disease: Multi-institutional comparative analysis of survival: International Journal of Urology. 23(6):465~471 (1.878)
2016 SCI-E PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: A retrospective study: Asian Journal of Andrology. Online:Published (2.644)
2016 SCI-E A case report of partial nephrectomy of mucinous cystadenocarcinoma in kidney and its literature review: Cancer research and treatment. 48(2):838~842 (4.245)
2016 SCI-E Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy: PloS one. 11(3):e0151646~e0151646 (3.057)
2016 기타 The establishment of KORCC (Korean Renal cell carcinoma) database: Investigative and clinical urology. 57:50~57 (0)
2015 SCI Overexpression of BRCA1 or BRCA2 in prostatectomy specimens is predictive of biochemical recurrence after radical prostatectomy: Histopathology. 68(5):673~679 (3.453)
2015 SCI-E Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study: PLOS ONE. 10(10):e0140693~e0140693 (3.234)
2015 SCI-E Clinicohistological characteristics of renal cell carcinoma in children :A multicentre study: Canadian Urological Association Journal. 9:E705~708 (0.866)
2015 SCI-E The quantified level of circulating prostate stem cell antigen mRNA relative to GAPDH level is a clinically significant indictor for predicting biochemical recurrence in prostate cancer patients after radical prostatectomy: BioMed Research International. 2015:292454~292454 (1.579)
2015 SCI-E Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study: PLOS One. 10(8):e~0135165 (3.234)
2015 SCI-E The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer.: BMC urology. 15:82~82 (1.413)
2015 기타 Oncologic aspects of long-term followed incidental prostate cancer detected by cystoprostatectomy in Korean patients.: Prostate international. 3(2):56~61 (0)
2015 SCI-E Changes in urination according to the sound of running water using a mobile phone application: PloS one [electronic resource]. 10(5):0126798~0126798 (3.234)
2015 SCI-E Overexpression of ERG and wild-type PTEN are associated with favorable clinical prognosis and low biochemical recurrence in prostate cancer: PloS one [electronic resource]. 10(4):0122498~0122498 (3.234)
2015 SCI-E Efficacy and oncologic safety of nerve-sparing radical hysterectomy for cervical cancer: a randomized controlled trial.: Journal of gynecologic oncology. 26(2):90~99 (2.494)
2014 기타 Predictive factors for maximal size reduction of renal target lesion in patients with metastatic renal cell carcinoma receiving targeted therapies: The Korean Journal of urological Oncology (대한비뇨기 종양 학술지). 12(3):1~8 (0)
2014 기타 Experience of successful treatment for an intractable advanced ureter cancer with extraureteral extension using omental flap transposition: A case report: Journal of Clinical Case Reports. :~ (0)
2014 SCI-E Use of targeted therapies for advanced renal cell carcinoma in the Asia-Pacific region: opinion statement from China, Japan, Taiwan, Korea, and Australia: Clinical Genitourinary Cancer. 12(4):225~233 (1.693)
2014 SCI Pelvic Floor Musculature and Bladder Neck Changes Before and After Continence Recovery After Radical Prostatectomy in Pelvic MRI: Journal of magnetic resonance imaging : JMRI. 39(6):1431~1435 (2.788)
2014 SCI Low C24-OH and C22-OH sulfatides in human renal cell carcinoma: Journal of mass spectrometry : JMS. 49(5):409~16 (2.709)
2014 SCI-E Treatment outcome of docetaxel plus prednisolone for metastatic castration-resistant prostate cancer in Korea: Journal of Cancer Research and Therapeutics. 10(2):251~257 (0.949)
2014 SCI-E Detection of Human Papillomavirus Infection and p16 Immunohistochemistry Expression in Bladder Cancer with Squamous Differentiation: PLOS one. 9(3):e93525~e93525 (3.534)
2013 SCI-E Genetic variations of α -methylacyl-CoA racemase are associated with sporadic prostate cancer risk in ethnically homogenous Koreans: Biomed Research International. 2013:1~11 (0)
2013 SCI Validation of the MSKCC and Heng Risk Criteria Models for Predicting Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: Annals of Surgical Oncology. 20(13):4397~4404 (4.12)
2013 SCI Overestimation of Nuclear Matrix Protein 22 in Concentrated Urine: Urology. 82(5):1059~1064 (2.424)
2012 SCI-E Urologic complications of laparoscopic radical hysterectomy and lymphadenectomy: International urogynecology journal. 23(11):1605~1611 (1.832)
2012 SCI Association of common variations of 8q24 with the risk of prostate cancer in Koreans and a review of the Asian population: British Journal of Urology International. 110(6ptB):E318~E325 (2.844)
2012 기타 Current Status of Targeted Therapy for Advanced Renal Cell Carcinoma: Korean Journal of Urology. 4:217~228 (0)
2012 SCI Adjuvant Intravesical Instillation for Primary T1G3 Bladder Cancer: BCG versus MMC in Korea: Anticancer research. 32(4):1493~1498 (1.725)
2011 SCI Haplotype Analysis of Prostate Stem Cell Antigen and Association With Prostate Cancer Risk.: The Journal of Urology. 185(6):2112~2118 (3.862)
2011 SCI Prostate Volume has Prognostic Value Only in Pathologic T2 Radical Prostatectomy Specimens: Journal of Korean Medical Science. 26:807~813 (0.834)
2011 SCI-E Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens: International journal of urology. 18(5):350~357 (1.46)
2011 SCI Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.: Cancer Chemotherapy and Pharmacology. 67:769~774 (2.759)
2011 SCI A prospective evaluation of conventional cystography for detection of urine leakage at the vesicourethral anastomosis site after radical prostatectomy based on computed tomography: Clinical Radiology. 66(3):251~256 (1.765)
2010 기타 A rapidly progressing bladder transitional cell carcinoma with sarcomatoid differentiation: The Korean Journal of Urological Oncology. 8(3):147~151 ()
2010 SCI-E Bcl-2 as a Predictive Factor for Biochemical Recurrence after Radical Prostatectomy: An Interim Analysis: Cancer Research and Treatment. 42:157~162 (0)
2010 SCI Prostate Specific Membrane Antigen mRNA in Blood as a Potential Predictor of Biochemical Recurrence after Radical Prostatectomy: Journal of Korean Medical Science. 25:1291~1295 (0.838)
2010 SCI Prognostic Value of p53 and Ki-67 Expression in Intermediate-risk Patients With Nonmuscle-invasive Bladder Cancer Receiving Adjuvant Intravesical Mitomycin C Therapy: Urology. 512:1~7 (2.365)
2010 SCI Pretreatment assessment of tumor enhancement on contrast-enhanced computed tomography as a potential predictor of treatment outcome in metastatic renal cell carcinoma patients receiving antiangiogenic therapy: cancer. 116(10):2332~2342 (5.418)
2010 SCI-E Lower urinary tract injuries diagnosed after hysterectomy: Seven-year experience at a cancer hospital: The Journal Of Obstetrics and Gynaecology Research. 36:318~325 (0.777)
2010 SCI Prostate Stem Cell Antigen mRNA in Peripheral Blood as a Potential Predictor of Biochemical Recurrence in High-Risk Prostate Cancer: Journal of Surgical Oncology. 101(2):145~148 (2.502)
2009 SCI Lymphovascular Invasion in Transurethral Resection Specimens as Predictor of Progression and Metastasis in Patients With Newly Diagnosed T1 Bladder Urothelial Cancer: Journal of Urology. 182:2625~2631 (3.952)
2009 기타 Familial Prostate Cancer in Three Brothers: The Korean Journal of Urology. 50(2):195~198 (0)
2009 SCI Incidental prostate cancer detected by cystoprostatectomy in Korean men: Urology. 73:153~157 (2.242)
2008 SCI Results of repeated transurethral resection for a second opinion in patients referred for nonmuscle invasive bladder cancer: The referral cancer center experience and review of the literature: Journal of Endourology. 22:2699~2704 (1.799)
2008 기타 Epidermal Growth Factor Receptor as Predicting Factor on Biochemical Recurrence after Radical Prostatectomy: A Prospective Study: The Korean Journal of Urology. 49:974~980 ()
2008 기타 Epidermal Growth Factor Receptor as Predicting Factor on Biochemical Recurrence after Radical Prostatectomy: A Prospective Study: The Korean Journal of Urology. 49:974~980 ()
2008 기타 Epidermal Growth Factor Receptor as Predicting Factor on Biochemical Recurrence after Radical Prostatectomy: A Prospective Study: Korean J Urol. 49:974~980 ()
2008 SCI-E Docetaxel Chemotherapy of Korean Patients with Hormone- refractory Prostate Cancer:Comparative Analysis between 1st-line and 2nd-line Docetaxel: Yonsei Medical Journal. 49:775~782 (0.781)
2008 SCI-E Identification of immunohistochemical factors that predict the synchronous or metachronous development of bladder tumors in patients with upper urinary tract tumors: Urologia Internationalis. 81:306~311 (0.82)
2008 SCI Single institutional experience of bladder-preserving trimodality treatment for muscle-invasive bladder cancer: Journal of Korean Medical Science. 23:598~603 (0.824)
2008 SCI The efficacy of transureteroureterostomy for ureteral reconstruction during surgery for a non-urologic pelvic malignancy: Journal of Surgical Oncology. 98:49~53 (2.384)
2008 SCI-E Clinical value of PTEN in patients with superficial bladder cancer: Urologia Internationalis. 80:264~269 (0.82)
2008 SCI Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy.: British Journal of Cancer. 98:89~90 (4.635)
2007 SCI The outcome with ureteric stents for managing non-urological malignant ureteric obstruction.: BJU International. 100(6):1288~1291 (2.635)
2007 SCI The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: Analysis of risk factors predicting recurrence and survival: Journal of Surgical Oncology. 96:560~568 (2.384)
2007 SCI Prevalence of high-grade prostatic intraepithelial neoplasia in prostate gland of Korean men: comparisons between radical prostatectomy and cystoprostatectomy: Urology. 70:1100~1103 (2.13)
2007 SCI Analysis of changes in the total lymphocyte and eosinophil count during immunotherapy for metastatic renal cell carcinoma: Correlation with response and survival: Journal of Korean Medical Science. 22S:S122~S128 (0.725)
2007 SCI-E Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer: International Journal of Urology(상위20# 이내 학술지 아님). 14:635~643 (0.691)
2007 기타 Adult's Wilms' tumor mimicking renal pelvis tumor: The Korean Journal of Urology. 48:558~560 ()
2007 기타 Adult's Wilms' tumor mimicking renal pelvis tumor: The Korean Journal of Urology. 48:558~560 ()
2007 SCI Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma: BJU International. 99:821~824 (2.247)
2007 기타 Partial Nephrectomy using Parenchymal Compression without Renal Pedicle Clamping: Korean J Urol. 49:265~269 ()
2006 기타 Adult Wilms' Tumor with Severe Adhesion to the Colon: Korean J Urol Oncol. 4:95~97 ()
2006 SCI-E Gastrointestinal Stromal Tumor in Ileal neobaldder: International Journal of Urology. 13:1451~1453 (0.629)
2004 SCI Impact of Transurethral resection of Bladder tumor: Analysis of Cystectomy specimens to evaluate for Residual tumor: UROLOGY. 63:873~877 (2.585)
2004 기타 Clinical Significance of p53, Retinoblastoma(Rb) and PTEN Expression in Bladder Cancer: Korean J Urol Oncol. 1:36~40 ()
2004 SCI Enhanced chemosensitivity of Bladder cancer cells to Cisplatin by Suppression of Clusterin in vitro: CANCER LETTERS. 203:155~161 (2.346)
2003 기타 Clinical Efficacy of Ki-67, Apoptotic Index, bcl-2, and p53 in Bladder Tumor: Correlation with Stage, Histologic Grade and Recurrence Rate: Korean J Urol Oncol. 2:376~381 ()
2000 SCI The Application of an anti-angiogenic Gene(thrombospondin- 1) in the Treatment of Human Prostate Cancer Xenografts: CANCER GENE THERAPY. 7:1537~1542 (3.653)
2000 기타 The Outcome of TRUS-guided Sextant Biopsy According to Prostate Volume: Korean J Urol. 4:505~511 ()
2000 기타 Ureteroscopic Management of Ureteral Calculi: Comparisons of Stone Basket, Electrohydraulic Lithotripsy, Swiss Lithoclast and Holmium:YAG Laser: Korean J Urol. 2:239~245 ()
2000 기타 Nephron Sparing Surgery in the Management of Renal Cell Carcinoma: Korean J Urol. 41:8~14 ()
2000 기타 Natural History of Refluxing Distal Ureteral Stumps following Upper Tract Surgery in Children with Ectopic Ureter or Ureterocele: Korean J Urol. 1:81~86 ()
1999 기타 Adult Testicular Germ Cell Tumor: Clinical Characteristics and Risk Factors for Recurrence: Korean J Urol. 40:1145~1151 ()
1999 기타 The Study for Chromosome 3p Loss in Renal Cell Carcinoma by Fluorescence in Situ Hybridization Using Paraffin-Embedded Tissue: Korean J Urol. 40:697~702 ()
1999 기타 The Effectiveness of oral Ciprofloxacin for Treatment of Chronic Prostatatis: Korean J Chemotherapy. 17:229~237 ()
1999 기타 Patterns of Tumor Recurrence after Nephron Sparing Surgery for Renal Cell Carcinoma: Korean J Urol. 40:687~690 ()
1999 기타 Growth Inhibitory Effects and Mechanisms of Ceramides in Renal Cell Carcinoma Cells: Korean J Urol. 40:285~291 ()
1999 기타 Prevalence of Benign Prostatic Hyperplasia in Jeong-Eup Area: Community-based Study: Korean J Urol. 40:52~58 ()
1998 기타 Use of Serum PSA in Comparison of Biopsy Gleason Score with Radical Prostatectomy Gleason Score: Korean J Urol. 39:1241~1247 ()
1998 기타 Age-specific Reference Ranges for Prostate-specific Antigen from a Community-based Study: Korean J Urol. 38:1065~1069 ()
1998 기타 The Significance of Atypical Cell in Urinary Cytology: Korean J Urol. 38:9~14 ()
1997 기타 The Change of Clinical Characteristics of Prostatic Cancer before and after the Introduction of Prostate Specific Antigen Assay: Korean J Urol. 38:270~274 ()
1997 기타 The Significance of the p53 Protein Overexpression as a Prognostic Marker in Transitional Cell Carcinoma of the Bladder Treated with Radical Cystectomy: Korean J Urol. 38:250~258 ()
1994 기타 The Effect of M-VAC(Methotrexate, Vinblastine, Doxorubicin and Cisplatin) chemotherapy for Advanced Transitional Cell Carcinoma: Journal of Korean Cancer Associaition. 24:618~625 ()
1993 기타 A study on the Cell Kinetics of transitional Cell Carcinoma of the Bladder: Measurements of DNA Content and proliferating Cell Nuclear Antigenl: Journal of Korean Cancer Association. 25:390~396 ()
1993 기타 Clinical Value of Prostate Specific Antigen(PSA) as A Tumor marker in Prostate Adenocarcinoma: Korean J Urol. 34:68~77 ()
1991 기타 Diabetic Neurogenic Bladder: Korean J Urol. 32:986~990 ()
